Search

everythinglearnresearchcommunity

for

Search:↓

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

The hydrogel promotes better wound healing by creating a fetal-like environment.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

i-PRF and A-PRF show promise in promoting hair regrowth and improving scalp health in androgenetic alopecia.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Elastin-like recombinamers show promise for better wound healing and skin regeneration.

AA-PRP injections significantly promote hair growth but need better study design for clear efficacy.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Ruxolitinib helped a patient with alopecia areata regrow hair.

The Enriched-GF method efficiently produces high-yield growth factors for tissue repair.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Both treatments promote hair growth safely, but stem cells are slightly more effective.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.